FinDogFinDog
Thursday, September 17, 2026Closing data · 4:00 PM ET
English
Log in

SYK

Stryker CorporationNYSE · Health Care Equipment · Health Care
Previous close
280.13
Change
−4.63 / −1.63%
FinDog View
Bullish
52-Week Range ?
267.00 – 392.55
P/E (TTM) ?
29.3
Forward P/E ?
21.8
Based on consensus earnings for the next 12 months
Market Cap
$109B
1M
−15.46%
S&P 500 −0.63% over same period
Volume / Avg Volume
2.4M / 3.8M
0.63× average
Latest earnings analysisFY2026 Q2Reported 2026-07-30

Stryker Q2 FY2026: sales up 9.4%, adjusted EPS $3.69, guidance narrowed

Stryker reported $6.589 billion of revenue for Q2 FY2026, up 9.4%, and adjusted EPS of $3.69 against a $3.5233 consensus, with both segments growing near 9%. Read the beat as real, and the narrowed guidance as a sign management sees the cyber recovery holding. But the reported 68.3% gross margin carries a $158 million reversal of 2025 tariffs inside it, so the durable margin is nearer 66.0%.

Read the full analysis →
Revenue$6.59BYoY +9.40%
EPS (non-GAAP)$3.69Beatest. $3.52
Next-day move−6.42%

Price History

Closing price · USD1M6M1Y5Y
100200300400500EEEEEE2021-092022-122024-032025-062026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 41.21M6M1Y5Y
20304050602025-092025-122026-032026-062026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Next Earnings

Date and consensus from the earnings calendar; the analysis is generated automatically after the releaseEarnings Calendar →
Report date
2026-10-29est.
in 41 days · Estimated from last year's report date; subject to company confirmation
Consensus EPS
Last quarter EPS $3.69
Avg. next-day move over the last 6 reports
±4.3%

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 1 of its 5-year rangeCheap
5-year range 35.3 – 52.0 · Median 41.9
Last 4 quarters: $0 in buybacks + $1.3B in dividends, 1.21% of market cap combined
P/E (TTM)
29.3
P/B
4.6
P/S
4.2
Dividend Yield
1.02%
Earnings Reaction
Over the last 6 reports, the stock moved ±4.3% on average on the first trading day after, rising 2 times
Most recent −6.42%
Volatility & Correlation
1-year beta 0.15 · Correlation with S&P 500 0.07Low beta
Annualized volatility 30% vs. 13% for the S&P 500
Insider Trading
View all
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 5 · $0.03MSell 4 · $118MNet selling $118M
  • 08-21Crotty Dylan BramGroup PresidentSell$0.14M441 shares · Avg price 328.61
  • 08-19STRYKER RONDA EDirectorSell$17.0M50,000 shares · 12 trades · Avg price 340.10
  • 08-18King DebraSee RemarksSell$0.28M826 shares · Avg price 336.30
  • 08-18STRYKER RONDA EDirectorSell$101M300,000 shares · 8 trades · Avg price 335.90
  • 11-22BRAINERD MARY KDirectorBuy$0.00M18 shares · Avg price 225.20
  • 06-12BRAINERD MARY KDirectorBuy$0.00M3 shares · Avg price 185.65
  • 05-12BRAINERD MARY KDirectorBuy$0.01M36 shares · Avg price 193.21
  • 09-12BRAINERD MARY KDirectorBuy$0.00M11 shares · Avg price 221.03
Multi-Quarter Financial Trends
View all quarters
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q26.59+9.4%68.3%1.661.281.063.30
FY2026 Q16.02+2.6%63.3%0.940.750.421.93
FY2025 Q47.17+11.4%0.851.882.20
FY2025 Q36.06+10.2%63.6%1.140.861.352.22
FY2025 Q26.02+11.1%63.8%1.110.880.932.29
FY2025 Q15.87+11.9%63.8%0.840.650.131.69
FY2024 Q46.44+10.7%0.551.671.41
FY2024 Q35.49+11.9%64.0%1.090.831.302.16
FY2024 Q25.42+8.5%63.0%1.050.830.482.14
FY2024 Q15.24+9.7%63.6%0.970.790.042.05
FY2023 Q45.82+11.8%1.141.382.98
FY2023 Q34.91+9.6%64.3%0.930.690.901.80

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView